Daniel Nöteberg

Design and Synthesis of Plasmepsin I and Plasmepsin II Inhibitors with Activity in <i>Plasmodium </i><i>f</i><i>alciparum</i>-Infected Cultured Human Erythrocytes

Daniel Nöteberg, Elizabeth Hamelink, Johan Hultén et al. · Journal of Medicinal Chemistry · 2003 · 88 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

High-Speed Optimization of Inhibitors of the Malarial Proteases Plasmepsin I and II

Daniel Nöteberg, Wesley Schaal, Elizabeth Hamelink et al. · Journal of Combinatorial Chemistry · 2003 · 69 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II

Daniel Muthas, Daniel Nöteberg, Yogesh Sabnis et al. · Bioorganic & Medicinal Chemistry · 2005 · 40 citations

Life Sciences, Biochemistry, Medicinal Chemistry +14

New Proline Mimetics:  Synthesis of Thrombin Inhibitors Incorporating Cyclopentane- and Cyclopentenedicarboxylic Acid Templates in the P2 Position. Binding Conformation Investigated by X-ray Crystallography

Daniel Nöteberg, Jonas Brånalt, Ingemar Kvarnström et al. · Journal of Medicinal Chemistry · 2000 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of 3-Cyano- <i>N</i> -(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 <i>H</i> -pyrrolo[2,3- <i>b</i> ]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist

Mark E. Schnute, Mattias Wennerstål, Jennifer Alley et al. · Journal of Medicinal Chemistry · 2018 · 32 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17